Poseida, Takeda partner to develop eight in vivo gene therapy programs

Poseida, Takeda partner to develop eight in vivo gene therapy programs

Submitted by admin on October 13, 2021 - 10:51am
Source: 
Pharmaceutical Business Review
News Tags: 
Takeda
Poseida Therapeutics
gene therapy
drug development
Headline: 
Poseida, Takeda partner to develop eight in vivo gene therapy programs
snippet: 

Poseida Therapeutics has signed a research collaboration and license agreement with Takeda Pharmaceutical Company to develop up to eight in vivo gene therapy programs.

Do Not Allow Advertisers to Use My Personal information